Kim S, Chung G, Kim S
Front Pain Res (Lausanne). 2025; 6:1537154.
PMID: 39958366
PMC: 11825757.
DOI: 10.3389/fpain.2025.1537154.
Mishra S, Mishra Y, Kumar A
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39797987
DOI: 10.1007/s00210-024-03667-7.
Zhang W, Zhang X, Lei M, Zhang D, Qin G, Zhou J
Antioxidants (Basel). 2024; 13(6).
PMID: 38929165
PMC: 11201052.
DOI: 10.3390/antiox13060725.
Cai H, Chen S, Sun Y, Zheng T, Liu Y, Tao J
Cell Commun Signal. 2024; 22(1):307.
PMID: 38831315
PMC: 11145867.
DOI: 10.1186/s12964-024-01688-6.
Jmel H, Boukhalfa W, Gouiza I, Seghaier R, Dallali H, Kefi R
Front Pharmacol. 2024; 15:1380613.
PMID: 38813106
PMC: 11134176.
DOI: 10.3389/fphar.2024.1380613.
α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca3.2 calcium signaling in astrocytes.
Leandrou E, Chalatsa I, Anagnostou D, Machalia C, Semitekolou M, Filippa V
Transl Neurodegener. 2024; 13(1):11.
PMID: 38378800
PMC: 10880263.
DOI: 10.1186/s40035-024-00401-4.
Identification of Novel Targeting Sites of Calcineurin and CaMKII in Human Ca3.2 T-Type Calcium Channel.
Chang Y, Chen Y, Chen C
Biomedicines. 2023; 11(11).
PMID: 38001892
PMC: 10669385.
DOI: 10.3390/biomedicines11112891.
RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.
Yang S, Luo Y, Zhou D, Xiang J, Xi X
Transl Cancer Res. 2023; 12(10):2556-2571.
PMID: 37969377
PMC: 10643971.
DOI: 10.21037/tcr-23-742.
Diabetes-Induced Amplification of Nociceptive DRG Neuron Output by Upregulation of Somatic T-Type Ca Channels.
Ivasiuk A, Matvieienko M, Kononenko N, Duzhyy D, Korogod S, Voitenko N
Biomolecules. 2023; 13(9).
PMID: 37759720
PMC: 10526307.
DOI: 10.3390/biom13091320.
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord.
Liu Q, Lu Z, Ren H, Fu L, Wang Y, Bu H
J Bone Oncol. 2023; 42:100495.
PMID: 37583441
PMC: 10423893.
DOI: 10.1016/j.jbo.2023.100495.
T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions.
Rangel-Galvan M, Rangel-Galvan V, Rangel-Huerta A
Front Pharmacol. 2023; 14:1212800.
PMID: 37529702
PMC: 10387653.
DOI: 10.3389/fphar.2023.1212800.
The dorsal root ganglion as a target for neurorestoration in neuropathic pain.
Estivill-Torrus G, Martinez-Padilla A, Sanchez-Salido L, Baron-Van Evercooren A, Garcia-Diaz B
Neural Regen Res. 2023; 19(2):296-301.
PMID: 37488881
PMC: 10503598.
DOI: 10.4103/1673-5374.374655.
Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain.
Antunes F, Campos M, Carvalho V, da Silva Junior C, Magno L, de Souza A
Int J Mol Sci. 2023; 24(11).
PMID: 37298174
PMC: 10252546.
DOI: 10.3390/ijms24119223.
Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels.
Gadotti V, Antunes F, Zamponi G
Mol Brain. 2023; 16(1):47.
PMID: 37231418
PMC: 10210369.
DOI: 10.1186/s13041-023-01036-8.
An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact.
Mallet C, Desmeules J, Pegahi R, Eschalier A
J Pain Res. 2023; 16:1081-1094.
PMID: 37016715
PMC: 10066900.
DOI: 10.2147/JPR.S393809.
Electrophysiological characterization of a Ca3.1 calcium channel mutation linked to trigeminal neuralgia.
Alaklabi A, Gambeta E, Zamponi G
Pflugers Arch. 2023; 475(6):711-718.
PMID: 37010626
DOI: 10.1007/s00424-023-02808-w.
Betulinic acid analogs inhibit N- and T-type voltage-gated calcium channels to attenuate nerve-injury associated neuropathic and formalin models of pain.
Calderon-Rivera A, Gomez K, Loya-Lopez S, Wijeratne E, Stratton H, Tang C
Neurobiol Pain. 2023; 13:100116.
PMID: 36687466
PMC: 9853350.
DOI: 10.1016/j.ynpai.2023.100116.
Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors.
Ovsepian S, Waxman S
Nat Rev Neurosci. 2023; 24(4):252-265.
PMID: 36658346
DOI: 10.1038/s41583-022-00673-7.
The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels.
Udoh M, Bladen C, Heblinski M, Luo J, Janve V, Anderson L
Front Pharmacol. 2022; 13:1048259.
PMID: 36386164
PMC: 9664070.
DOI: 10.3389/fphar.2022.1048259.